Carbidopa/levodopa: Difference between revisions
Content deleted Content added
Davidruben (talk | contribs) |
No edit summary |
||
| Line 10: | Line 10: | ||
{{pharma-stub}} |
{{pharma-stub}} |
||
[[Category:Antiparkinsonian agents]] |
[[Category:Antiparkinsonian agents]] |
||
This does not help in the least bit. |
|||
Revision as of 22:47, 20 February 2008
The combination of carbidopa and levodopa is used to treat Parkinson's disease and Dopa-Responsive Dystonia (DRD). The generic name under the British Approved Name system is Co-careldopa. It is sold under several brand names, including Sinemet;, Parcopa, and Atamet.
External links
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This does not help in the least bit.